Intravenous Immunoglobulins Versus Plasma Exchange in the Treatment of Guillain-Barré Syndrome

Critical Care - United Kingdom
doi 10.1186/cc7272
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cost-Effectiveness Analysis of 10% Intravenous Immunoglobulin Compared With Plasma Exchange in Treatment of Children With Guillain–Barré Syndrome in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Plasmapheresis Treatment in Guillain-Barré Syndrome: Potential Benefit Over Intravenous Immunoglobulin

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2010English

Guillain-Barré Syndrome

2020English

Macrohematuria in Guillain-Barré Syndrome After the Treatment With Intravenous Γ-Globulin. A Case Report.

Nihon Shoni Jinzobyo Gakkai Zasshi
1995English

Guillain-Barré Syndrome: Surveillance and Cost of Treatment Strategies

The Lancet
Medicine
2017English

Intravenous Immune Globulins in Patients With Guillain-Barre Syndrome and Contraindications to Plasma Exchange: 3 Days Versus 6 Days

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2001English

Guillain-Barré Syndrome in the Course of Dengue

Journal of the Neurological Sciences
Neurology
2015English

Immunoglobulin G Fc N-Glycosylation in Guillain-Barré Syndrome Treated With Intravenous Immunoglobulin

Clinical and Experimental Immunology
AllergyImmunology
2014English

Successful Treatment for Toxic Epidermal Necrolysis/Drug-Induced Hypersensitivity Syndrome Overlap With Corticosteroids, Intravenous Immunoglobulins and Plasma Exchange

Journal of Clinical & Experimental Dermatology Research
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy